Premark HS Vitamin RDA Premix
Reason Product manufactured with an ingredient that contains low levels of soy; soy is not declared on product label.
iXL Advanced Performance Matrix recall
Recalled by McShare's Inc · Salina, KS, United States
Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.
Why it was recalled
Product manufactured with an ingredient that contains low levels of soy; soy is not declared on product label.
Undeclared allergen: Soy
For someone with a food allergy the label is the only protection. An undeclared allergen can trigger a severe reaction even in a trace amount, which is why most of these recalls are Class I. All undeclared allergens recalls.
What was recalled
iXL Advanced Performance Matrix, Nutritional Premix, Net Wt. 50 lbs., Item No. 136375.
Quantity: 3600 lbs.
Lot codes, dates and UPCs
A recall covers only these codes. Compare them with the lot number, best-by date or UPC printed on your package.
Lot numbers and Expiration dates: IXL-180516-20, 5/18/2017 IXL-180516-21, 5/18/2017 IXL-210117-50, 1/21/2018
Where it was sold
Missouri Texas
FDA's distribution note: Product was distributed for further manufacturing to customers in MO and TX.
Low risk, but check. Class III means the product is unlikely to make anyone ill but breaks an FDA rule, often a labeling one. If your package matches, the store will normally refund it. The risk from an undeclared allergen is to people allergic to soy; for anyone else the product is generally not a safety concern. FDA lists this recall as terminated: the company has finished removing the product, so it should no longer be on shelves - but it can still be in a freezer or pantry.
- Recalling firm
- McShare's Inc
- Initiated by
- Voluntary: Firm initiated
- Recall initiated
- Mar 11, 2017
- In FDA report of
- Apr 12, 2017
- Terminated
- Apr 21, 2017
- FDA recall number
- F-1862-2017 · event 76731
- Official record
- FDA enforcement report search
Also recalled with it (1 more product)
FDA files each product of one recall action separately; these share the same FDA event.